Skip to main content

Table 1 Baseline Clinical Characteristics of the 361 Patients at Initial Recurrence

From: Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification

Characteristics

Value

Age at initial recurrence, years (IQR)

54.1 (44.0–63.0)

Treatment for primary HCC

 Surgical resection

230 (63.7)

 Ablation

131 (36.3)

First recurrence-free survival, months (IQR)

24.9 (7.4–32.7)

Initial recurrent tumor diameter, mm (IQR)

18.4 (12.0–23.0)

Initial recurrent tumor number

 Single

308 (85.3)

 Multiple

53 (14.7)

Treatment for initial recurrence

 Ablation

280 (77.6)

 TACE + Ablation

81 (22.4)

  1. TACE transcatheter arterial chemoembolization, IQR interquartile range